Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

(2014) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel

(2013) D. L. Hertz et al.   ANNALS OF ONCOLOGY

Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy

(2013) Ellen M. Lavoie Smith et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Successful Treatment by Adding Duloxetine to Pregabalin for Peripheral Neuropathy Induced by Paclitaxel

(2012) Motoyasu Takenaka et al.   American Journal of Hospice & Palliative Medicine

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

(2012) G. Cavaletti et al.   ANNALS OF ONCOLOGY

Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment

(2011) D R Pachman et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools

(2010) Guido Cavaletti et al.   EUROPEAN JOURNAL OF CANCER

A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA

(2010) Debra L. Barton et al.   SUPPORTIVE CARE IN CANCER

Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy

(2008) Ravi D. Rao et al.   CANCER

Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms

(2007) Anna-Liisa Kautio et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT